Literature DB >> 12054600

Enhanced SUMOylation in polyglutamine diseases.

Hiroko Ueda1, Jun Goto, Hideji Hashida, Xia Lin, Kiyomitsu Oyanagi, Hitoshi Kawano, Huda Y Zoghbi, Ichiro Kanazawa, Hitoshi Okazawa.   

Abstract

Small ubiquitin-like modifiers (SUMOs) are proteins homologous to ubiquitin that possibly regulate intranuclear protein localization, nuclear transport, and ubiquitination. We examined patients of DRPLA, SCA1, MJD, and Huntington's disease and found that neurons in affected regions of the brain react strongly to SUMO-1, a family member of SUMOs. Western blot with a transgenic mouse expressing mutant ataxin-1 showed the increase of SUMOylated proteins in the cerebellar cortex, which we named ESCA1 and ESCA2. These results indicated activation of SUMO-1 system in polyglutamine diseases and predicted its involvement in the pathology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054600     DOI: 10.1016/S0006-291X(02)00211-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Cardiac function and disease: emerging role of small ubiquitin-related modifier.

Authors:  Jun Wang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

2.  A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers.

Authors:  Germán Rosas-Acosta; William K Russell; Adeline Deyrieux; David H Russell; Van G Wilson
Journal:  Mol Cell Proteomics       Date:  2004-11-30       Impact factor: 5.911

Review 3.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

Review 4.  Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.

Authors:  Dagmar E Ehrnhoefer; Liza Sutton; Michael R Hayden
Journal:  Neuroscientist       Date:  2011-02-10       Impact factor: 7.519

Review 5.  Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.

Authors:  Hyoungseok Ju; Hiroshi Kokubu; Janghoo Lim
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

6.  Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation.

Authors:  Yong Man Kim; Won Hee Jang; Martha M Quezado; Yohan Oh; Kwang Chul Chung; Eunsung Junn; M Maral Mouradian
Journal:  J Neurol Sci       Date:  2011-06-08       Impact factor: 3.181

7.  Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant huntingtin and manganese.

Authors:  Michal Wegrzynowicz; Hunter K Holt; David B Friedman; Aaron B Bowman
Journal:  J Proteome Res       Date:  2012-01-20       Impact factor: 4.466

Review 8.  Sumoylation in neurodegenerative diseases.

Authors:  Petranka Krumova; Jochen H Weishaupt
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

Review 9.  Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease.

Authors:  Vincenzo Bonifati; Ben A Oostra; Peter Heutink
Journal:  J Mol Med (Berl)       Date:  2004-01-08       Impact factor: 4.599

Review 10.  Protein SUMOylation in neuropathological conditions.

Authors:  Dina B Anderson; Kevin A Wilkinson; Jeremy M Henley
Journal:  Drug News Perspect       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.